Silence Therapeutics (SLN) Goodwill (2018 - 2026)

Silence Therapeutics has disclosed Goodwill across 9 years of filings, most recently posting $10.4 million for Q1 2026.

• Goodwill for Q1 2026 came in at $10.4 million, down 2.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.4 million (down 2.48% YoY), and the FY2025 annual result was $10.6 million, up 13.09% from the prior year.
• Goodwill came in at $10.4 million for Q1 2026 at Silence Therapeutics, down from $10.6 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $10.6 million in Q1 2025 to a low of $9.4 million in Q3 2024.
• The 5-year median for Goodwill is $10.1 million (2024), against an average of $10.0 million.
• Across the five-year window, Goodwill dropped 8.21% in 2022 and grew 13.09% in 2025, its largest moves.
• Silence Therapeutics' Goodwill stood at $9.4 million in 2022, then increased by 3.58% to $9.7 million in 2023, then fell by 3.48% to $9.4 million in 2024, then rose by 13.09% to $10.6 million in 2025, then dropped by 2.48% to $10.4 million in 2026.
• The last three Goodwill figures came in at $10.4 million (Q1 2026), $10.6 million (Q4 2025), and $10.6 million (Q3 2025), per Business Quant data.